Trial Profile
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza-immune-globulin-Emergent-BioSolutions (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Therapeutic Use
- Acronyms INSIGHT 006
- 19 Aug 2019 Status changed from recruiting to completed.
- 21 Jun 2019 This trial is completed in Greece according to European Clinical Trials Database record
- 02 Feb 2019 This trial has been completed in UK - MHRA, according to European Clinical Trials Database.